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Abstract
The genome of Mycobacterium tuberculosis H37Rv contains three
contiguous genes (plc-a, plc-b and plc-c) which are similar to the
Pseudomonas aeruginosa phospholipase C (PLC) genes. Expression
of mycobacterial PLC-a and PLC-b in E. coli and M. smegmatis has
been reported, whereas expression of the native proteins in M. tuber-
culosis H37Rv has not been demonstrated. The objective of the
present study was to demonstrate that native PLC-a is expressed in M.
tuberculosis H37Rv. Sera from mice immunized with recombinant
PLC-a expressed in E. coli were used in immunoblots to evaluate
PLC-a expression. The immune serum recognized a 49-kDa protein in
immunoblots against M. tuberculosis extracts. No bands were visible
in M. tuberculosis culture supernatants or extracts from M. avium, M.
bovis and M. smegmatis. A 550-bp DNA fragment upstream of plc-a
was cloned in the pJEM12 vector and the existence of a functional
promoter was evaluated by detection of ß-galactosidase activity. ß-
Galactosidase activity was detected in M. smegmatis transformed with
recombinant pJEM12 grown in vitro and inside macrophages. The
putative promoter was active both in vitro and in vivo, suggesting that
expression is constitutive. In conclusion, expression of non-secreted
native PLC-a was demonstrated in M. tuberculosis.
Correspondence
S.C. Leão
Departamento de Microbiologia,
Imunologia e Parasitologia
EPM, UNIFESP
Rua Botucatu, 862, 3º andar
04023-062 São Paulo, SP
Brasil
Fax: +55-11-5571-6504
E-mail: sylvia@ecb.epm.br
Research supported by FAPESP
(No. 97/06506-6). T. Matsui was the
recipient of a CAPES fellowship.
Part of a Master’s thesis presented
by T. Matsui to the Departamento
de Microbiologia, Imunologia e
Parasitologia, UNIFESP, São Paulo,
SP, Brazil.
Received February 8, 2000
Accepted July 27, 2000
Key words
· Mycobacterium tuberculosis
· Phospholipase C
· Gene expression
· Promoters
Introduction
Tuberculosis is an ancient disease, but its
immunopathogenic mechanisms are still not
well understood. Fundamental questions still
exist about which antigens are involved in
the generation of a protective immune re-
sponse in humans and their participation in
pathogenicity. Several mycobacterial anti-
gens have been recently characterized, some
of them expressed exclusively in bacteria of
the Mycobacterium tuberculosis complex,
which consists of four pathogenic members
(M. tuberculosis, M. bovis, M. africanum,
and M. microti) and one non-pathogenic
member (M. bovis BCG) (1). Differences in
biological characteristics essential for patho-
genesis, potentially determined by expres-
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sion of species-specific proteins, are prob-
ably responsible for the unique pathogenic
properties and world distribution of M.
tuberculosis. Identification and character-
ization of M. tuberculosis species-specif-
ic proteins is an essential step in research
directed at the elucidation of the specific
immunopathogenic mechanisms of tuber-
culosis.
A 3.0-kb BamHI DNA fragment was iden-
tified in an M. tuberculosis genomic library
and sequenced (2,3). The analysis of its nucle-
otide sequence revealed the existence of two
open reading frames (ORF) coding for highly
similar proteins. A comparative search also
showed great similarity between these ORFs
and two phospholipase C (PLC) genes of
Pseudomonas aeruginosa (3-5). The M. tu-
berculosis H37Rv genome project revealed
the existence of three similar consecutive
genes - plc-a, plc-b and plc-c (6). The host
range of the plc site is still a matter of debate,
but probes derived from the 3.0-kb fragment
did not hybridize with genomes of other
mycobacteria, including members of the M.
tuberculosis complex (2).
PLC-a was expressed in Escherichia coli
and recombinant clones were found to pre-
sent hemolytic activity (3). PLC-a and PLC-
b were expressed in M. smegmatis and the
recombinant clones, as well as M. tuberculo-
sis H37Rv, were found to have PLC activity
(7).
PLC has been described as a virulence
factor of Pseudomonas aeruginosa (8), Ba-
cillus cereus (9), Listeria monocytogenes
(10) and Clostridium perfringens (11,12).
An enzyme with this activity may have an
active role in tuberculosis, participating in
different pathogenic processes attributed to
M. tuberculosis infection, such as contact-
dependent cytolytic activity (13) and lysis of
the phagolysosome membrane (14). It may
participate in the acquisition of phosphate,
as was demonstrated for P. aeruginosa PLC
(15). It could also modify protein kinase C
cell signaling by generation of diacylgly-
cerol, interfere with the activation of phago-
cytic cells and amplify the inflammatory
response by arachidonic acid production.
Apoptosis by induction of cytotoxic activity
has been observed with P. aeruginosa (16)
and M. tuberculosis (17).
For this reason, it is of fundamental im-
portance to determine if the proteins coded
by the plc-a, plc-b and plc-c genes are ex-
pressed by M. tuberculosis and under which
conditions. Here, the expression of native
PLC-a was demonstrated in M. tuberculosis
by immunoblot. Promoter activity of a 550-
bp fragment from the upstream region of plc-
a was detected in recombinant mycobacteria
grown in vitro and in vivo. These results
confirmed that the first PLC gene, plc-a, is
expressed, suggesting that this protein could
be biologically relevant during the course of
the disease.
Material and Methods
Bacterial strains, plasmids, and macrophage
cell line
Escherichia coli JM101 and E. coli
BL21(DE3) (Novagen, Madison, WI, USA)
were grown in Luria Bertani (LB) medium
(18) at 37oC in a shaking incubator. M.
smegmatis mc2155 was grown in 7H9 liquid
medium (Difco, Detroit, MI, USA) or 7H10
agar (Difco) plates supplemented with oleic
acid, albumin, dextrose, and catalase (OADC;
Difco). Ampicillin (100 µg/ml; Bayer, Sªo
Paulo, SP, Brazil) and kanamycin (15 µg/ml;
Sigma Chemical Co., St. Louis, MO, USA)
were the antibiotics used for selection pur-
poses. X-gal (5-bromo-4-chloro-3-indolyl-
ß-D-galactoside) (Gibco-BRL, Rockville,
MD, USA) was used as a substrate for ß-
galactosidase. Bacterial strains were stored
at -20oC in liquid medium plus 15% glycer-
ol.
M. tuberculosis H37Rv, M. bovis
AN5, and M. avium D4 were a gift from
Dr. Eliana Roxo, Instituto Biológico, Sªo
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Paulo, SP, Brazil.
The plasmid used for expression was
pET23a (Novagen). pJEM12, an E. coli-
mycobacterial shuttle plasmid containing a
promotorless ß-galactosidase gene, was a
gift from Dr. Brigitte Gicquel, Pasteur Insti-
tute, Paris, France (19).
The J774 mouse macrophage cell line
was maintained in RPMI medium 1640
(Gibco-BRL) supplemented with 10% fetal
calf serum in an incubator with 5% CO2, at
37oC.
Cloning and expression strategies
A 1533-bp DNA fragment containing the
plc-a ORF region was amplified by PCR
with primers PET1: 5’-GCAAGgatcCGC
AAGCCCAC-3’ [positions 434 to 543 of the
sequence reported in (3)] and PET2: 5’-
GGTGTGGaTcCCTGAGTTGG-3’ [1966 to
1947] (positions modified to create BamHI
restriction sites are in lower case letters and
BamHI sites are underlined). The amplicon
was cloned into the BamHI-restricted pET23a
vector. Recombinant clones were introduced
into E. coli BL21(DE3) by electroporation.
Isolated ampicillin-resistant colonies were
grown in LB-ampicillin liquid medium and
PLC-a expression was induced with 0.1 mM
isopropylthio-ß-galactoside (IPTG) for 4 h
at 37oC.
A 550-bp fragment containing the
initial 125 nucleotides of the plc-a coding
region was amplified by PCR using primers
JEM1: 5’-TCAGCCGgatCCACCAGAGTC-
3’ [positions 14 to 34] and JEM2: 5’-
CCCGGatCCGTAGGCCTTTTC-3’ [posi-
tions 543 to 563]. The fragment was cloned
into BamHI-digested pJEM12. Competent
E. coli JM101 were transformed with the
ligation product by electroporation and re-
combinant clones were selected on LB-kana-
mycin agar plates. Recombinant plasmids
were purified by minipreparation and intro-
duced into competent M. smegmatis by
electroporation (20).
The orientation of the cloned fragments
was confirmed by restriction analysis and
DNA sequencing using an Automated Laser
Fluorescence Sequencer (Amersham Phar-
macia Biotech Inc., Piscataway, NJ, USA).
using the Sequenase kit and primers labeled
with FluorePrime fluorescein Amidite
(Amersham Pharmacia Biotech).
Localization and purification of recombinant
PLC-a
After induction with IPTG, recombinant
E. coli BL21(DE3) was collected by cen-
trifugation at 3000 g, washed twice with
phosphate-buffered saline (PBS) and resus-
pended in 1/50 volumes PBS. Bacteria were
sonicated with a Branson Sonifier 450
(Branson Sonic Power Co., Danbury, CT,
USA) with pulses of 15-s duration and cen-
trifuged at 12000 g for 5 min. Whole ex-
tracts, pellet and supernatant were submitted
to sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) on 10%
acrylamide gels. Periplasmic proteins were
extracted from 2 ml induced E. coli cultures
by adding 15 µl of chloroform to the bacte-
rial pellet and incubating at room tempera-
ture for 15 min. Seventy-five microliters of
10 mM Tris-HCl, pH 8.0, was added, the
solution was centrifuged and the supernatant
analyzed by SDS-PAGE.
The recombinant protein was cut from
preparative SDS-PAGE gels, eluted with 25
mM Tris-HCl, pH 8.3, 250 mM glycine,
0.1% (w/v) SDS for 24 h, dialyzed against
PBS and concentrated with a Speed-vac ap-
paratus (Savant Instruments Inc., Farming-
dale, NY, USA).
Animal immunization
Six female BALB/c mice were immu-
nized with the eluted recombinant protein by
subcutaneal injections at four sites. Fifty
micrograms of protein in PBS, emulsified
with incomplete Freunds adjuvant (v/v), was
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injected per site on days 0, 30, 45 and every
two months thereafter.
Immunoblots
Recombinant E. coli induced with IPTG
was centrifuged, resuspended in loading buf-
fer, and submitted to SDS-PAGE. M. tuber-
culosis H37Rv, M. bovis AN5, M. avium D4,
and M. smegmatis mc2155 were grown in
Sauton medium (21) at 37oC until the sur-
face of the medium was covered. Bacilli
were inactivated at 80oC for 30 min, centri-
fuged at 3000 g for 15 min and resuspended
in PBS at a concentration of 1 g/ml. One
hundred milligrams of whole cell extract
was submitted to electrophoresis on 10%
SDS-polyacrylamide gels. After SDS-PAGE,
proteins were transferred to nitrocellulose
filters (Hybond-C, Amersham), which were
first incubated with immune serum (1:100 in
PBS plus 0.05% Tween 20) for 2 h and then
with goat anti-mouse peroxidase-conjugated
antibodies (Promega Corp., Madison, WI,
USA) (1:7500 in PBS-Tween 20). The reac-
tion was developed with ECL reagents
(Amersham) or with 4-chloro-1-naphthol
(Sigma).
Detection of promoter activity
M. smegmatis transformed with recom-
binant and non-recombinant pJEM12 was
grown in 7H9-OADC-kanamycin liquid me-
dium for 2 days at 37oC in a shaker. Bacteria
were distributed on 7H10-OADC-kanamy-
cin-X-gal agar plates and incubated for 2 to 3
days at 37oC.
Liquid cultures (A600 nm 0.6 to 1) were
centrifuged at 3000 g for 15 min and resus-
pended in 150 µl of lysis buffer from the ß-
galactosidase enzyme assay system (Pro-
mega). Five microliters of chloroform and
SDS at a final concentration of 0.1% were
added and the tubes were incubated at 37oC
for 5 min. Assay buffer (150 µl) from the kit
was added and the reaction was incubated at
37oC until the development of yellow color.
A standard curve was obtained using ß-ga-
lactosidase (Promega). The reaction was
stopped with 0.5 ml 1 M Na2CO3, samples
were centrifuged at 12000 g for 5 min and
the absorbance at 420 nm was read in an
Ultrapec-Plus spectrophotometer (Pharma-
cia). ß-Galactosidase units (U) were calcu-
lated using the formula:
A420 nm x 1000   = ß-galactosidase (U)
T x V x A600 nm
where T = incubation (h) and V = culture
volume (ml).
Macrophages cultured on 30-mm culture
Petri dishes (Falcon, Becton Dickinson and
Co., Lincoln Park, NJ, USA) were infected
with recombinant and non-recombinant M.
smegmatis from liquid cultures at a 10:1
infection rate for 4 h at 37oC. Extracellular
bacteria were killed with gentamicin, 50 µg/
ml, for 2 h and 5 µg/ml for an additional 24
h. Cells were washed several times in sterile
PBS and fixed with 0.5% glutaraldehyde
(Sigma) in PBS for 16 h at 4oC. Two millili-
ters of 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,
2 mM MgCl2 and 1 mg/ml X-gal were added
and the plates were incubated overnight at
37oC. Macrophages were observed under an
Axovert S100 inverted microscope (Zeiss,
Jena, Germany) and ß-galactosidase activity
was detected as a blue precipitate inside the
cells.
Results
To demonstrate expression of native PLC-
a in M. tuberculosis H37Rv, a specific anti-
PLC-a immune serum was produced by im-
munization of mice with recombinant PLC-a
expressed in E. coli. To obtain the recombi-
nant protein, the plc-a insert was amplified
by PCR and cloned into the pET23a expres-
sion vector. A 59-kDa insoluble recombi-
nant protein with a poly-histidine C-terminal
tail, not present in the periplasmic fraction,
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Figure 2 - Immunoblots with anti-PLC-a mouse serum.
Lane 1, Recombinant protein eluted from the gel. Lane
2, Extract of E. coli BL21(DE3) transformed with pET23a
harboring the complete plc-a fragment. Lane 3, E. coli
BL21(DE3) transformed with non-recombinant pET23a.
Lane 4, E. coli JM101 transformed with pGEX-5T har-
boring the complete plc-a ORF fragment. Lane 5, E. coli
JM101 transformed with pGEX-5T harboring the plc-a
ORF fragment without the 5' region coding for the
putative signal peptide. Lane 6, E. coli JM101 trans-
formed with non-recombinant pGEX-5T. Lane 7, Non-
transformed E. coli JM101. Numbers at left indicate
molecular mass in kDa.
Figure 1 - Polyacrylamide gel (10% acrylamide) stained
with Coomassie blue showing the localization of re-
combinant PLC-a expressed from pET23a. Lane 1, E.
coli BL21(DE3) transformed with pET23a harboring a
PLC-a ORF - whole cell extract after sonication. Lane 2,
Sonicated extract supernatant. Lane 3, Sonicated ex-
tract pellet. Lane 4, Periplasmic fraction proteins. Lane
5, Mid-range protein molecular weight marker
(Promega). The arrow shows the recombinant protein.
kDa
- 97.4
- 66.2
- 55
- 42.7
- 40
- 31
1 2 3 4 5
was expressed after induction with IPTG
(Figure 1). The recombinant protein was
insoluble, which made its purification by
affinity to nickel ions difficult. Recombinant
PLC-a could be solubilized with ionic deter-
gent (sarcosyl) or in 20 mM Tris-HCl, pH
11, 0.5 M NaCl, plus 6 M urea, but subse-
quent purification on an Ni-nitrilo-triacetic
acid resin column (Ni-NTA, Qiagen Inc.,
Valencia, CA, USA) resulted in very low
binding and elution yields (data not shown).
Finally, the protein was eluted from acryl-
amide gels and used for immunization.
Immune sera obtained from 6 animals
were tested for anti-PLC-a activity in ELISA
against eluted PLC-a. The most reactive se-
rum (limit dilution, 1:50,000) was used in
the experiments described below.
The specificity of the anti-PLC-a mouse
serum was evaluated using immunoblots
against different recombinant and non-re-
combinant E. coli. The immune serum rec-
ognized recombinant PLC-a expressed from
pET23a and also from previous pGEX-5T
constructions (3). No cross-reactivity with
E. coli proteins was observed (Figure 2).
When this serum was used in immuno-
blots against extracts of different mycobac-
teria, a single 49-kDa band was detected
exclusively in M. tuberculosis H37Rv ex-
tracts (Figure 3). No bands were visible in
extracts from M. avium, M. bovis or M.
smegmatis or in a 4-week M. tuberculosis
culture supernatant, suggesting that PLC-a is
an M. tuberculosis-specific non-secreted pro-
tein.
To confirm expression of native PLC-a,
an upstream plc-a ORF fragment was cloned
in pJEM12 and a functional promoter pre-
sent in this insert was identified by detection
of ß-galactosidase activity in M. smegmatis
transformed with recombinant pJEM12. Blue
colonies were produced on 7H10-OADC-
kanamycin-X-gal agar plates (Figure 4A)
and ß-galactosidase production was con-
firmed by tests performed with the ß-galac-
tosidase enzyme assay system (Table 1).
Colonies of M. smegmatis harboring a plas-
mid with the insert in the inverted orienta-
tion showed no blue precipitate on X-gal
agar plates and showed ß-galactosidase ac-
tivity similar to that of non-recombinant M.
1kDa
83
62
47.5
2 3 4 5 6 7
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smegmatis in the liquid assay. These results
substantiated the existence of a promoter in a
plc-a upstream region, which is active in
bacteria grown in vitro, indicating that the
plc-a gene is transcribed in this condition.
Promoter activity in bacteria growing in-
side cells was evaluated in J774 macrophages
infected with recombinant M. smegmatis.
Bacteria turned blue after substrate addition
(Figure 4B) confirming activity of the plc-a
promoter, and consequently gene transcrip-
tion, both in vitro and in vivo. Non-recombi-
nant M. smegmatis and recombinant M.
smegmatis harboring the plasmid with the
insert in inverted orientation showed no blue
precipitate (data not shown).
The 550-bp fragment contains the first
125 bp from the plc-a-coding region. A se-
quence that matches 9 of 18 residues with an
E. coli Pho box was previously identified
between positions 369 and 386 (3). Four
hexamers similar to the E. coli TATAAT-
10-consensus sequence were identified at
positions 89 (TAGTTT), 205 (TAATTT),
212 (TACTGT), and 388 (TAACGT).
These results provide evidence that PLC-
a is a non-secreted, constitutively expressed
M. tuberculosis-specific protein.
Discussion
Multigene families have been described
in mycobacteria, i.e., 85 complex, PE-PPE,
and PLC genes, and could be a source of
antigenic variation representing important
elements for bacterial survival. The absence
of plc genes in other mycobacteria led to the
hypothesis of their participation in the path-
ogenic mechanisms of M. tuberculosis. The
demonstration of expression of PLC-a shown
here is evidence that PLC participates in M.
tuberculosis metabolism or virulence. The
fact that M. bovis, lacking the three plc genes,
can also be pathogenic for men and animals
could be explained by the existence of a
fourth plc gene, plc-d, that was deleted from
Figure 4 - Expression of ß-galactosidase in recombinant M. smegmatis. A, 7H10-OADC-
kanamycin-X-gal agar plates. M. smegmatis mc2155 transformed with pJEM12 containing
the insert in correct orientation is indicated by asterisks. B, J774 macrophages infected with
M. smegmatis transformed with pJEM harboring the insert in correct orientation.
Arrowsheads show cells with a blue precipitate indicative of ß-galactosidase activity.
59 kDa
49 kDa
1 32 4 5 6
Figure 3 - Immunoblotting with anti-PLC-a serum. Lane 1, Four-week M. tuberculosis
culture supernatant; lane 2, M. tuberculosis whole cell extract; lane 3, M. bovis whole cell
extract; lane 4, recombinant PLC-a; lane 5, M. avium whole cell extract, and lane 6, M.
smegmatis whole cell extract.
Table 1 - ß-Galactosidase expression.
A: M. smegmatis mc2155, B: M. smegmatis trans-
formed with non-recombinant pJEM12, C: M.
smegmatis transformed with recombinant
pJEM12 containing the insert in correct orienta-
tion, D: M. smegmatis transformed with recombi-
nant pJEM12 containing the insert in inverted ori-
entation.
Bacteria A420 nm ß-Galactosidase (U)
A 0.128 0.95
B 0.056 0.41
C 0.321 2.38
D 0.170 1.26
A B
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the genome of M. tuberculosis H37Rv, but is
present in the genomes of other members of
the M. tuberculosis complex (6).
In order to demonstrate that PLC-a was
expressed in M. tuberculosis, the protein had
to be purified. Purification of native myco-
bacterial proteins is a technically difficult
process because large amounts of bacilli are
necessary and the complex wall requires
complex and laborious lysis and purification
steps. Recent advances in mycobacterial ge-
netics and availability of antigens in recom-
binant form have provided the opportunity
to evaluate, for example, specific immune
responses directed against them (22). Ex-
pression of mycobacterial antigens in non-
pathogenic organisms like E. coli and Sac-
charomyces cerevisiae can be enhanced by
placing genes under the control of strong
promoters, and has the additional advantage
of permitting safer working conditions.
We have previously shown that E. coli
transformed with recombinant pGEX-5T
expressing PLC-a had hemolytic activity,
suggesting that the protein was active when
expressed in this system (3). The GST-fu-
sion PLC-a was insoluble, which impaired
purification by affinity chromatography with
glutathione or nickel. The recombinant pro-
tein could be solubilized with ionic deter-
gents such as sarcosyl, suggesting that inter-
action with membranes could be an impor-
tant contribution to the insolubility of this
protein. A different PLC-a fragment lacking
the first 78 nucleotides, coding for an N-
terminal hydrophobic region, was also ex-
pressed in pGEX-5T and presented the same
solubility impairment, suggesting that the N-
terminal region was not responsible for the
insolubility (data not shown). Expression in
S. cerevisiae resulted also in an insoluble
protein (data not shown), indicating that this
was not a specific phenomenon when E. coli
was used as a host. Non-fused PLC-a, ex-
pressed in pET23a, shown here, was also
insoluble. Bacterial phospholipases must gain
access to membranes for phospholipid hy-
drolysis. The precise mechanism by which
these enzymes bind to membranes remains
unclear, but presumably they possess hydro-
phobic regions that can be exposed after
conformational changes take place upon in-
teraction with the membrane surface (23).
Considering the difficulty in obtaining
pure soluble recombinant PLC-a, mice were
immunized with the protein eluted from the
gels. Recognition of PLC-a by these immune
sera was highly specific as shown by immu-
noblotting against proteins expressed from
different vectors in which different plc-a
fragments were cloned. Figure 2 shows that
immune serum recognized more than one
band in recombinant clones (lanes 2, 4, and
5). As no cross-reactivity with E. coli pro-
teins was observed (lanes 3, 6, and 7), the
most plausible explanation for the recogni-
tion of more than one band is protein degra-
dation, a frequent observation with recombi-
nant proteins (24).
Absorbance values obtained by ELISA
with the immune serum against M. tubercu-
losis whole cells were higher than against M.
smegmatis whole cells, but the difference
was not statistically significant (data not
shown). The most reactive immune serum
did not detect the protein in the culture su-
pernatant by immunoblot. These results sug-
gest that the native protein can be expressed
on the bacterial surface and that it is not
secreted. No bands were visible in M. avium,
M. bovis or M. smegmatis extracts, confirm-
ing the M. tuberculosis specificity previ-
ously reported (2).
The calculated mass of the protein recog-
nized in M. tuberculosis extracts was 49
kDa, as shown in Figure 3. Since GTG at
position 438 is the initiation codon, the cal-
culated mass of PLC-a was 56 kDa. Differ-
ences in molecular mass (mobility) of the
native protein could be partly explained by
hydrolysis of the putative signal sequence
(3), which would result in a 52-kDa protein.
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